Medical Condition News

RSS

Study compares needle fasciotomy and conventional surgery for Dupuytren's contractures

For disabling hand contractures caused by Dupuytren's disease, patients prefer a percutaneous needle fasciotomy procedure despite the higher contracture recurrence rate when compared to conventional surgery.

31 Jan 2012

AHA, NetLearning expand relationship to distribute additional course offerings

NetLearning, part of Cengage Learning and a leading provider of online courses and eLearning software for healthcare workers and hospital administrators, today announced an expanded relationship with the American Heart Association (AHA), the leader in emergency cardiovascular care resources, to distribute additional course offerings.

31 Jan 2012

Interim results from Allos Therapeutics' FOLOTYN and bexarotene Phase 1 combination study on CTCL

Allos Therapeutics, Inc. today reported interim results from the Company's ongoing Phase 1 combination study of FOLOTYN and bexarotene in patients with relapsed or refractory cutaneous T-cell lymphoma.

31 Jan 2012

The V Foundation for Cancer Research, PVH partner to offer new neckwear line

PVH Corp., one of the world's largest apparel companies, and The V Foundation for Cancer Research, one of the nation's leading cancer research fundraising organizations, announced a new partnership to offer The V Foundation Neckwear Collection - a line of ties inspired by memorable current and past sports figures.

31 Jan 2012

MentorCONNECT, NEDA team up for 2nd Annual 'Virtual Walk'

As part of the 2012 National Eating Disorders Awareness Week, February 26-March 3, the National Eating Disorders Association (NEDA) and MentorCONNECT have teamed up for the 2nd Annual "Virtual Walk," a social media-driven fundraising and awareness event.

31 Jan 2012

Bioton and Actavis form joint venture

Actavis and Bioton announced today that they have formed a joint venture company for the development and registration of insulins, including analogue insulins.

31 Jan 2012

Lycopene can kill prostate cancer cells

A nutrient in cooked tomatoes has been shown in laboratory studies to slow the growth of or even kill prostate cancer cells.

31 Jan 2012

ESC welcomes 'intriguing' study on heart failure

The European Society of Cardiology (ESC) welcomes an "intriguing" study, published today in the Journal of the American College of Cardiology, featuring a completely novel approach for improving endothelial function in heart failure.

31 Jan 2012

HSP40/70 linked to hepatitis C infection

Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks viral replication, which can lead to liver cancer and cirrhosis.

31 Jan 2012

Janssen, Orexo to end OX-CLI/OX-ESI research collaboration and license agreement

Orexo AB and Janssen Pharmaceuticals, Inc., formerly Ortho-McNeil-Janssen Pharmaceuticals, Inc. and Janssen Pharmaceutica NV, have decided to end their research collaboration and license agreement regarding the OX-CLI and OX-ESI programs and a third, undisclosed Janssen program.

31 Jan 2012

Ariz. hospitals fighting losses in political shift and in court; Ga. seeking second cancer center

A look at hospital news around the country also includes reports on a Mayo collaboration in Minnesota on immigrant health, plans for a proton cancer therapy center in South Florida and efforts by Tufts Medical Center to get a level one trauma center.

31 Jan 2012

ISCB honors CMU professor with Overton Prize

The International Society for Computational Biology (ISCB) has awarded its Overton Prize for outstanding accomplishment to Ziv Bar-Joseph, associate professor in Carnegie Mellon University's Lane Center for Computational Biology and Machine Learning Department.

31 Jan 2012

Tobacco smoking may increase risk of esophageal cancer in Barrett's patients

Barrett's esophagus (BE) patients who smoke tobacco are at a two-fold increased risk of developing esophageal cancer, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. BE patients who smoke also double their risk for developing advanced precancerous cells.

31 Jan 2012

Musical training can avoid age-related hearing loss

Age-related delays in neural timing are not inevitable and can be avoided or offset with musical training, according to a new study from Northwestern University. The study is the first to provide biological evidence that lifelong musical experience has an impact on the aging process.

31 Jan 2012

TomTec to launch 2D Cardiac Performance Analysis MR software

At the upcoming SCMR meeting in Orlando Florida at February 2nd -5th TomTec introduces its 2D Cardiac Performance Analysis MR software product. The tool to quantify myocardial function and deformation based on regular cardiac MRI cine imaging.

31 Jan 2012

Engineers discover electrical property in arteries

The heart's inner workings are mysterious, perhaps even more so with a new finding. Engineers at the University of Washington have discovered an electrical property in arteries not seen before in mammalian tissues.

31 Jan 2012

FDA approves Genentech's Erivedge for treatment of BCC

Genentech, a member of the Roche Group, today announced that Erivedge (vismodegib) capsule was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with a type of skin cancer, called basal cell carcinoma (BCC), that has spread to other parts of the body or that has come back after surgery or that their healthcare provider decides cannot be treated with surgery or radiation.

31 Jan 2012

Juventas' JVS-100 Phase I heart failure trial meets primary safety endpoint

Juventas Therapeutics is a privately-held, clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease. The Company's lead product, JVS-100, encodes Stromal cell-Derived Factor 1 (SDF-1) which has been shown to repair damaged tissue through recruitment of circulating stem cells to the site of injury, prevention of ongoing cell death and restoration of blood flow.

31 Jan 2012

Key Surgical launches Be Healthy 2012 program

Key Surgical, a leading supplier of sterile processing and operating room supplies, is launching a year-long program to encourage its employees to adopt new, healthier lifestyles. And if the company's employees achieve a set level of healthy activities, they can earn a 1% year-end bonus - for simply getting healthier!

31 Jan 2012

Genentech receives FDA approval for Erivedge to treat basal cell carcinoma

Today, Erivedge (vismodegib) was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The drug is intended for use in patients with locally advanced basal cell cancer who are not candidates for surgery or radiation and for patients whose cancer has spread to other parts of the body.

31 Jan 2012